Tower Research Capital LLC (TRC) - INFLARX NV ownership

INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 1 filers reported holding INFLARX NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INFLARX NV
ValueSharesWeighting
Q3 2023$23,906
+185.3%
8,022
+326.9%
0.00%
Q2 2023$8,380
+93011.1%
1,879
-59.6%
0.00%
Q1 2023$9
+50.0%
4,646
+128.0%
0.00%
Q4 2022$6
-99.9%
2,038
-22.9%
0.00%
Q3 2022$7,000
+40.0%
2,643
-29.8%
0.00%
Q2 2022$5,000
+400.0%
3,764
+1529.4%
0.00%
Q4 2021$1,000
-95.7%
231
-95.0%
0.00%
-100.0%
Q4 2020$23,000
+155.6%
4,590
+135.1%
0.00%
Q3 2020$9,000
-10.0%
1,952
-6.0%
0.00%
Q2 2020$10,000
+900.0%
2,076
+689.4%
0.00%
Q1 2020$1,000
-97.6%
263
-97.4%
0.00%
-100.0%
Q4 2019$41,000
+925.0%
10,175
+596.4%
0.00%
Q3 2019$4,000
-60.0%
1,461
-52.8%
0.00%
-100.0%
Q2 2019$10,000
-68.8%
3,098
+262.8%
0.00%
-50.0%
Q1 2019$32,000
+45.5%
854
+43.0%
0.00%0.0%
Q4 2018$22,000
-83.6%
597
-84.7%
0.00%
-80.0%
Q3 2018$134,000
+45.7%
3,905
+36.7%
0.01%
+100.0%
Q2 2018$92,000
+26.0%
2,857
+13.2%
0.01%
-16.7%
Q1 2018$73,000
+812.5%
2,524
+569.5%
0.01%
+500.0%
Q4 2017$8,0003770.00%
Other shareholders
INFLARX NV shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,766,038$56,955,00017.85%
RA Capital Management 1,967,148$63,441,0004.12%
Cormorant Asset Management, LP 1,487,265$47,964,0003.55%
Redmile Group, LLC 2,027,700$65,393,0002.22%
EMORY UNIVERSITY 77,554$2,501,0001.66%
Eventide Asset Management 275,000$8,869,0000.37%
Birchview Capital, LP 16,000$516,0000.35%
Artal Group S.A. 500,000$16,125,0000.34%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,385,659$76,938,0000.18%
Baker Brothers Advisors 258,824$8,347,0000.06%
View complete list of INFLARX NV shareholders